Safety and Efficacy of different antiplatelet regimens in Patients With Acute Coronary Syndrome Treated With Elective Percutaneous Coronary Intervention

Wei Beilei; MeiWang

首页> 外文期刊>Journal of the American College of Cardiology >Safety and Efficacy of different antiplatelet regimens in Patients With Acute Coronary Syndrome Treated With Elective Percutaneous Coronary Intervention

【24h】

Safety and Efficacy of different antiplatelet regimens in Patients With Acute Coronary Syndrome Treated With Elective Percutaneous Coronary Intervention

机译：用选修经皮冠状动脉介入治疗急性冠状动脉综合征患者不同抗血小板治疗的安全性和有效性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the American College of Cardiology》 |2017年第16期|共1页
作者
Wei Beilei; MeiWang;
展开▼
作者单位

Hebei Med Univ Hosp 2 Shijiazhuang Hebei Peoples R China;

Hebei Med Univ Hosp 2 Shijiazhuang Hebei Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Safety and Efficacy of different antiplatelet regimens in Patients With Acute Coronary Syndrome Treated With Elective Percutaneous Coronary Intervention [J] . Wei Beilei, MeiWang Journal of the American College of Cardiology . 2017,第16期

机译：用选修经皮冠状动脉介入治疗急性冠状动脉综合征患者不同抗血小板治疗的安全性和有效性
2. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention [J] . Jiao Yungen, Hu Feng, Zhang Zhengang, Clinical drug investigation . 2015,第12期

机译：负荷剂量瑞舒伐他汀治疗老年经皮冠状动脉介入治疗的急性冠状动脉综合征的疗效和安全性
3. One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study [J] . T. Yetgin, E. Boersma, P. C. Smits, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation . 2018,第7a8期

机译：经皮冠状动脉介入治疗急性冠脉综合征患者常规普拉格雷的一年疗效和安全性：前瞻性rijnmond集体心脏病研究的结果
4. Evaluation of Matrix Metalloproteinase-9 (MMP-9) and its tissue inhibitor of metalloproteinase-1 (Timp-1) in patients with coronary syndromes after percutaneous intervention(PCI) [C] . Revnic F., Revnic C.R., Nica A., International Congress on Coronary Artery Disease . 2011

机译：经皮干预后冠状动脉综合征患者中基质金属蛋白酶-9（MMP-9）及其组织抑制剂及其组织抑制剂（PCI）
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Efficacy and safety of an antithrombotic regimen for atrial fibrillation patients with acute coronary syndrome or those undergoing percutaneous coronary intervention: a meta-analysis [O] . Wenqin Guo, Xiehui Chen, Yunling Hao, 2020

机译：心房颤动患者的抗血栓形成方案的疗效和安全性急性冠状动脉综合征或经皮冠状动脉介入的人：荟萃分析
7. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention [O] . Stephan Windecker, Renato D. Lopes, Tyler Massaro, 2019

机译：心房颤动和急性冠状动脉综合征患者的抗血栓治疗医学或经皮冠状动脉介入或接受选修经皮冠状动脉介入治疗

Safety and Efficacy of different antiplatelet regimens in Patients With Acute Coronary Syndrome Treated With Elective Percutaneous Coronary Intervention

著录项

相似文献

相关主题

期刊订阅